Bicara Therapeutics Inc. Common Stock (BCAX) vs Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

A side-by-side comparison of Bicara Therapeutics Inc. Common Stock and Lumexa Imaging Holdings, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bicara Therapeutics Inc. Common Stock logo
BCAX
Bicara Therapeutics Inc. Common Stock
$1.09B
$16.60HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Lumexa Imaging Holdings, Inc. Common Stock logo
LMRI
Lumexa Imaging Holdings, Inc. Common Stock
$1.03B
$10.68HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — BCAX vs LMRI

growth of $100 · dividends reinvested · last 1y
BCAX -8.3% (-8.3%/yr)LMRI -41.8% (-41.8%/yr)BCAX compounded faster over this window
50100150Start $1002026$92$58
BCAX LMRI

BCAX vs LMRI: by the numbers

  • •BCAX is the larger company ($1.09B vs $1.03B market cap).
  • •Both run net losses; BCAX's is the smaller (0.00% vs -2.66% net margin).

Metrics side by side

Valuation

MetricBCAXLMRI
Forward P/EN/A16.64
P/S ratioN/A0.98
P/B ratio2.331.67
EV / EBITDAN/A28.03
FCF yieldN/A3.10%

Profitability

MetricBCAXLMRI
Gross margin0.00%11.80%
Operating margin0.00%1.38%
Net margin0.00%-2.66%
ROE-39.54%-4.51%
ROIC-42.98%0.86%

Go deeper

Full BCAX analysisFull LMRI analysisInteractive comparison tool

Dig into the metrics

Bicara Therapeutics Inc. Common Stock ROELumexa Imaging Holdings, Inc. Common Stock ROEBicara Therapeutics Inc. Common Stock operating marginLumexa Imaging Holdings, Inc. Common Stock operating marginBicara Therapeutics Inc. Common Stock revenue growthLumexa Imaging Holdings, Inc. Common Stock revenue growthBicara Therapeutics Inc. Common Stock free cash flowLumexa Imaging Holdings, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.